反方观点:成熟动静脉内瘘的血管通路监测是否值得?
本文针对血液透析成熟动静脉内瘘的血管通路监测是否值得进行论述。作者指出当前缺乏高质量证据、诊断截点不明确、对狭窄>50%的干预指征存在争议,且内瘘血流动力学复杂。现有证据显示监测虽能发现更多狭窄并增加操作次数,但是否改善患者重要结局仍不确定,需开展设计良好的随机对照研究。
要点
- 现有证据不支持成熟动静脉内瘘常规监测能改善患者重要结局。
- 监测可发现更多狭窄并增加操作次数,但内瘘通畅率获益不确定。
- 需明确干预指征并开展随机对照研究,现行指南应允许此类研究。
核心结论
- 成熟动静脉内瘘的血管通路监测虽能发现更多狭窄并增加操作次数,但是否改善患者重要结局仍不确定。
研究设计与样本
- 本文为针对成熟动静脉内瘘血管通路监测是否值得的论述性文章,未报告系统检索范围或样本量。
主要发现
- 现有证据提示,与单纯临床监测相比,动静脉内瘘监测可发现更多狭窄并导致操作次数增加。
- 监测是否延长动静脉内瘘通畅率等患者重要结局仍不确定。
- 动静脉内瘘血流动力学复杂,随透析时间、位置、血管大小和狭窄位置变化。
关键数值与推荐
- 对狭窄>50%不加区分地采取干预的「膝跳反射」式做法是否恰当存在疑问。
- 不同监测技术诊断动静脉内瘘狭窄的截点缺乏明确性。
- 需开展随机对照研究,采用明确的干预指征、可重复的干预方法和临床重要的内瘘及患者结局。
临床怎么用
- 临床不应仅依据狭窄>50%的监测结果常规干预,应结合临床指标综合判断。
- 需区分血管通路监测、临床监测与抢先干预三种策略对患者重要结局的影响。
局限性
- 缺乏稳健、高质量且患者重要结局一致可比的证据。
- 不同监测技术诊断狭窄的截点不明确。
- 现有指南需修订以允许开展必要的随机对照研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The risks and benefits of hemodialysis arteriovenous (AV) access surveillance have been debated since the introduction of AV access surveillance techniques. The debate is fuelled by the lack of robust, high-quality evidence with consistent and comparable patient-important outcomes. Additionally, there is a lack of clarity regarding the diagnostic cut points for AV access stenosis using the various surveillance techniques, questions about the appropriateness of the 'knee-jerk' response to intervention on a stenosis >50% regardless of the presence of clinical indicators and whether the intervention results in desired patient-important outcomes. The physiology of the AV access is complex considering the different hemodynamics within an AV fistula, which vary by time of dialysis, location, size of vessels and location of the stenosis. The current evidence suggests that the use of AV access surveillance in an AV fistula does detect more stenosis compared with clinical monitoring alone and leads to an increased number of procedures. It remains uncertain if that leads to improved patient-important outcomes such as prolonged AV fistula patency. Vascular access is an essential component of hemodialysis and further study is needed to clarify this long-standing debate. There needs to be better distinction between the strategies of vascular access surveillance, clinical monitoring with clinical indictors and preemptive intervention and their respective impacts on patient-important outcomes. Randomized controlled studies must be conducted with defined indications for intervention, reproducible methods of intervention and clinically important AV fistula and patient outcomes. The current guidelines need to be challenged and revised to permit these necessary studies to be done.
引用
- Moist L, Lok CE. Con: Vascular access surveillance in mature fistulas: is it worthwhile? Nephrol Dial Transplant. 2019. PMID: 30768169. doi:10.1093/ndt/gfz004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。